dostarlimab
gsk
['rectal', 'dostarlimab']
phase ii, single-arm, open-label study of dostarlimab monotherapy in previously untreated patients with stage ii/iii dmmr/msi-h locally advanced rectal cancer. #asco23 #asco2023 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News